应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02315 百奥赛图-B
休市中 12-05 16:09:06
32.200
+1.220
+3.94%
最高
33.200
最低
31.080
成交量
52.45万
今开
31.480
昨收
30.980
日振幅
6.84%
总市值
143.93亿
流通市值
35.74亿
总股本
4.47亿
成交额
1,675万
换手率
0.47%
流通股本
1.11亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
港股异动 | 百奥赛图-B(02315)涨超3% 授权IDEAYA双抗ADC项目IDE034获FDA IND批准
智通财经 · 12-05 14:46
港股异动 | 百奥赛图-B(02315)涨超3% 授权IDEAYA双抗ADC项目IDE034获FDA IND批准
百奥赛图-B(02315)业务合作伙伴IDEAYA取得美国食品药品监督管理局对IDE034的IND批准
智通财经 · 12-05 08:09
百奥赛图-B(02315)业务合作伙伴IDEAYA取得美国食品药品监督管理局对IDE034的IND批准
百奥赛图连续三年荣获“最具价值医药及医疗公司”奖项,彰显卓越创新实力与行业影响力
百奥赛图 · 12-04 19:00
百奥赛图连续三年荣获“最具价值医药及医疗公司”奖项,彰显卓越创新实力与行业影响力
双引擎赋能新药研发,百奥赛图以硬核技术引领全球医药创新浪潮
时代财经 · 11-28
双引擎赋能新药研发,百奥赛图以硬核技术引领全球医药创新浪潮
百奥赛图-B11月27日主力净流出435.0万元 散户资金买入
市场透视 · 11-27
百奥赛图-B11月27日主力净流出435.0万元 散户资金买入
百奥赛图-B(02315)将发行4750万股新A股 每股定价26.68元
中金财经 · 11-27
百奥赛图-B(02315)将发行4750万股新A股 每股定价26.68元
百奥赛图-B(02315)就首次公开发行A股股票将于11月27日举行网上路演
智通财经 · 11-26
百奥赛图-B(02315)就首次公开发行A股股票将于11月27日举行网上路演
百奥赛图-B(02315.HK)盘中涨超7%
每日经济新闻 · 11-24
百奥赛图-B(02315.HK)盘中涨超7%
百奥赛图-B盘中异动 股价大涨5.85%
市场透视 · 11-24
百奥赛图-B盘中异动 股价大涨5.85%
医药生物行业小核酸药物:三家标杆2026年的催化剂有哪些?
华福证券 · 11-23
医药生物行业小核酸药物:三家标杆2026年的催化剂有哪些?
“国产GPU第一股”来了,下周两只新股可申购
长沙晚报 · 11-23
“国产GPU第一股”来了,下周两只新股可申购
广发证券:国内投融资研发需求修复 关注制药板块左侧布局机会
智通财经 · 11-20
广发证券:国内投融资研发需求修复 关注制药板块左侧布局机会
港股异动 | 百奥赛图-B(02315)盘中涨近7% 科创板IPO下周初步询价 前三季度实现扭亏为盈
智通财经 · 11-20
港股异动 | 百奥赛图-B(02315)盘中涨近7% 科创板IPO下周初步询价 前三季度实现扭亏为盈
百奥赛图-B(02315):A股发行将于11月25日进行初步询价
智通财经 · 11-20
百奥赛图-B(02315):A股发行将于11月25日进行初步询价
百奥赛图:首次公开发行股票并在科创板上市发行安排及询价公告
公司公告 · 11-19
百奥赛图:首次公开发行股票并在科创板上市发行安排及询价公告
临床前CRO以及生物技术企业百奥赛图(688796.SH)拟于科创板IPO上市
智通财经网 · 11-19
临床前CRO以及生物技术企业百奥赛图(688796.SH)拟于科创板IPO上市
百奥赛图-B11月19日遭主力抛售108.7万元
市场透视 · 11-19
百奥赛图-B11月19日遭主力抛售108.7万元
百奥赛图-B11月18日遭主力抛售7.1万元
市场透视 · 11-18
百奥赛图-B11月18日遭主力抛售7.1万元
港股生物医药股逆势走高!百济神州涨超7%,百奥赛图-B涨超6%
老虎资讯综合 · 11-13
港股生物医药股逆势走高!百济神州涨超7%,百奥赛图-B涨超6%
百奥赛图-B11月10日主力净流出63.4万元 散户资金买入
市场透视 · 11-10
百奥赛图-B11月10日主力净流出63.4万元 散户资金买入
加载更多
公司概况
公司名称:
百奥赛图-B
所属市场:
SEHK
上市日期:
--
主营业务:
百奥赛图(北京)医药科技股份有限公司是一家主要提供抗体药物研发和临床前研究服务的中国公司。该公司运营五个分部。基因编辑服务分部提供基于动物和细胞的定制化基因编辑服务。临床前药理药效评估分部提供用于药物疗效和毒性评估的临床前药理学服务。模式动物销售分部培育和销售外用和内用模式动物,亦向客户授出若干模式动物的许可。抗体开发分部识别有潜力成为候选药物的抗体,并就潜在治疗性抗体分子对外授权或与合作伙伴合作。创新药开发分部研发创新药,专注肿瘤学和自身免疫性疾病治疗。
发行价格:
--
{"stockData":{"symbol":"02315","market":"HK","secType":"STK","nameCN":"百奥赛图-B","latestPrice":32.2,"timestamp":1764922146406,"preClose":30.98,"halted":0,"volume":524500,"delay":0,"floatShares":111000000,"shares":447000000,"eps":0.09277998541316397,"marketStatus":"休市中","change":1.22,"latestTime":"12-05 16:09:06","open":31.48,"high":33.2,"low":31.08,"amount":16750250,"amplitude":0.068431,"askPrice":32.2,"askSize":1500,"bidPrice":32.02,"bidSize":500,"shortable":0,"etf":0,"ttmEps":0.36664024731459,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":7,"adr":0,"listingDate":1661961600000,"exchange":"SEHK","adjPreClose":30.98,"openAndCloseTimeList":[[1764898200000,1764907200000],[1764910800000,1764921600000]],"volumeRatio":1.0710376708147946,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02315","defaultTab":"news","newsList":[{"id":"2589448869","title":"港股异动 | 百奥赛图-B(02315)涨超3% 授权IDEAYA双抗ADC项目IDE034获FDA IND批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2589448869","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589448869?lang=zh_cn&edition=full","pubTime":"2025-12-05 14:46","pubTimestamp":1764917191,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,百奥赛图-B涨超3%,截至发稿,涨2.84%,报31.86港元,成交1299.1万港元。IDEAYA预计将在2026年第一季度开始患者入组,初步评估B7H3和PTK7共表达的实体瘤类型,包括肺癌、结直肠癌、头颈癌及卵巢/妇科肿瘤。此外,IDEAYA计划探索IDE034与其PARG抑制剂IDE161的联合治疗策略,以增强疗效持续性,并计划在2026年上半年重要医学会议上分享更多支持PARG与TOP1 ADC联合治疗机制的数据。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378080.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4080","IND","BK1161","688796","ADC","BK4231","02315"],"gpt_icon":0},{"id":"2589855702","title":"百奥赛图-B(02315)业务合作伙伴IDEAYA取得美国食品药品监督管理局对IDE034的IND批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2589855702","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589855702?lang=zh_cn&edition=full","pubTime":"2025-12-05 08:09","pubTimestamp":1764893379,"startTime":"0","endTime":"0","summary":"IDEAYA预计将在2026年第一季度开始患者入组,初步评估B7H3和PTK7共表达的实体瘤类型,包括肺癌、结直肠癌、头颈癌及卵巢╱ 妇科肿瘤。B7H3和PTK7在肺癌、结直肠癌及头颈癌等实体瘤中的共表达比例分别约为30%、46% 和27%,显示IDE034广泛的临床适应症潜力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377962.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IND","BK1161","688796","02315"],"gpt_icon":1},{"id":"2589383664","title":"百奥赛图连续三年荣获“最具价值医药及医疗公司”奖项,彰显卓越创新实力与行业影响力","url":"https://stock-news.laohu8.com/highlight/detail?id=2589383664","media":"百奥赛图","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589383664?lang=zh_cn&edition=full","pubTime":"2025-12-04 19:00","pubTimestamp":1764846017,"startTime":"0","endTime":"0","summary":"2025年12月3日,在由智通财经与新智基金网联合主办、冬日暖阳 Donova 独家承办的 “第十届智通财经上市公司颁奖盛典” 上,百奥赛图再次荣获“最具价值医药及医疗公司”奖项。百奥赛图采用开放灵活的模式持续推进全球商务合作,截至2025年上半年,公司累计签署约300项抗体合作协议,成为全球抗体药物研发的重要赋能者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204200217a4cc9c7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204200217a4cc9c7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","09939","BK1574","BK1515","BK1161"],"gpt_icon":0},{"id":"2587739534","title":"双引擎赋能新药研发,百奥赛图以硬核技术引领全球医药创新浪潮","url":"https://stock-news.laohu8.com/highlight/detail?id=2587739534","media":"时代财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587739534?lang=zh_cn&edition=full","pubTime":"2025-11-28 09:01","pubTimestamp":1764291668,"startTime":"0","endTime":"0","summary":"11月28日,国内创新药研发赋能头部企业百奥赛图(北京)医药科技股份有限公司正式启动科创板新股申购。据弗若斯特沙利文的数据,百奥赛图RenMab小鼠平台是目前全球范围内已知的人源化程度最高的小鼠平台之一。技术壁垒与商业成功的核心保障,是百奥赛图全方位的知识产权布局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128090333a7163e9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128090333a7163e9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1515","02315","688796","09939","BK1161"],"gpt_icon":0},{"id":"2586899220","title":"百奥赛图-B11月27日主力净流出435.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2586899220","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586899220?lang=zh_cn&edition=full","pubTime":"2025-11-27 16:15","pubTimestamp":1764231324,"startTime":"0","endTime":"0","summary":"11月27日, 百奥赛图-B股价跌2.00%,报收32.40元,成交金额1905.6万元,换手率0.52%,振幅6.84%,量比0.83。百奥赛图-B今日主力资金净流出435.0万元,上一交易日主力净流入69.6万元。该股近5个交易日上涨1.25%,主力资金累计净流出492.9万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出464.3万元,其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127161648a714c747&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127161648a714c747&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315","688796"],"gpt_icon":0},{"id":"2586968522","title":"百奥赛图-B(02315)将发行4750万股新A股 每股定价26.68元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586968522","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586968522?lang=zh_cn&edition=full","pubTime":"2025-11-27 07:07","pubTimestamp":1764198421,"startTime":"0","endTime":"0","summary":"智通财经APP讯,百奥赛图-B(02315)公布,于2025年11月25日完成向询价对象进行的初步询价后,公司将按发行价每股A股人民币26.68元发行4750万股新A股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251127/31826495.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02315","159982","399300","688796","BK1161"],"gpt_icon":0},{"id":"2586402813","title":"百奥赛图-B(02315)就首次公开发行A股股票将于11月27日举行网上路演","url":"https://stock-news.laohu8.com/highlight/detail?id=2586402813","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586402813?lang=zh_cn&edition=full","pubTime":"2025-11-26 06:35","pubTimestamp":1764110130,"startTime":"0","endTime":"0","summary":"智通财经APP讯,百奥赛图-B 公布,公司首次公开发行人民币普通股(A股)并在科创板上市的申请已经上海证券交易所上市审核委员会审议通过,并已经中国证券监督管理委员会同意注册。本次公开发行股票数量为4750万股,发行股份占公司发行后总股本的比例为10.63%,全部为公开发行新股,不设老股转让。本次发行初始战略配售发行数量为950万股,占发行数量的20.00%,最终战略配售数量与初始战略配售数量的差额将首先回拨至网下发行。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1373623.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["399300","688796","159982","02315","BK1161"],"gpt_icon":0},{"id":"2585437063","title":"百奥赛图-B(02315.HK)盘中涨超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585437063","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585437063?lang=zh_cn&edition=full","pubTime":"2025-11-24 11:37","pubTimestamp":1763955463,"startTime":"0","endTime":"0","summary":"每经AI快讯,百奥赛图-B(02315.HK)盘中涨超7%,截至发稿,涨4.87%,报31.9港元,成交额1135.72万港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511243572760429.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511243572760429.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","688796","02315"],"gpt_icon":0},{"id":"2586949143","title":"百奥赛图-B盘中异动 股价大涨5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586949143","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586949143?lang=zh_cn&edition=full","pubTime":"2025-11-24 09:33","pubTimestamp":1763948027,"startTime":"0","endTime":"0","summary":"2025年11月24日早盘09时33分,百奥赛图-B股票出现波动,股价急速拉升5.85%。截至发稿,该股报32.200港元/股,成交量1.51万股,换手率0.01%,振幅6.25%。资金方面,该股资金流入36.548万港元,流出9.548万港元。百奥赛图-B股票所在的生物技术行业中,整体涨幅为1.36%。其相关个股中,帝王国际投资、银诺医药-B、MIRXES-B涨幅较大,振幅较大的相关个股有华康生物医学、银诺医药-B、MIRXES-B,振幅分别为11.76%、11.05%、7.43%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124093347a70d1690&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124093347a70d1690&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2585885481","title":"医药生物行业小核酸药物:三家标杆2026年的催化剂有哪些?","url":"https://stock-news.laohu8.com/highlight/detail?id=2585885481","media":"华福证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585885481?lang=zh_cn&edition=full","pubTime":"2025-11-23 20:07","pubTimestamp":1763899631,"startTime":"0","endTime":"0","summary":"投资要点:行情回顾:本周中信医药指数上跌6.8%,跑输沪深300指数3.0pct,在中信一级行业分类中排名第25位;2025年初至今中信医药生物板块指数上涨14.7%,跑赢沪深300指数1.5pct,在中信行业分类中排名第14位。Alnylam公司治疗ATTR的大单品AMVUTTRA今年有望成为首个销售额突破20亿美金的小核酸药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251123200722977a9946&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251123200722977a9946&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02359","03347","01530","BK1161","00853","02315","09926"],"gpt_icon":0},{"id":"2585481881","title":"“国产GPU第一股”来了,下周两只新股可申购","url":"https://stock-news.laohu8.com/highlight/detail?id=2585481881","media":"长沙晚报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585481881?lang=zh_cn&edition=full","pubTime":"2025-11-23 19:20","pubTimestamp":1763896810,"startTime":"0","endTime":"0","summary":"摩尔线程是国产GPU龙头,上市后将成为“国产GPU第一股”。摩尔线程本次发行后总股本为4.7亿股,上市时总市值将达537亿元。招股书显示,摩尔线程主要从事GPU及相关产品的研发、设计和销售,自2020年成立以来已推出四代GPU架构,并拓展出覆盖AI智算、云计算和个人智算等应用领域的计算加速产品矩阵。百奥赛图预计其2025年全年的营业收入为13.51亿元,同比增长37.75%;归母净利润为1.35亿元,同比增长303.57%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251123192302a70c2d18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251123192302a70c2d18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2584218343","title":"广发证券:国内投融资研发需求修复 关注制药板块左侧布局机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2584218343","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584218343?lang=zh_cn&edition=full","pubTime":"2025-11-20 15:13","pubTimestamp":1763622783,"startTime":"0","endTime":"0","summary":"CDMO行业业绩已触底回升,基于新签订单及新分子的旺盛研发需求,各公司2026年有望延续业绩优秀增长的趋势。广发证券主要观点如下:国内投融资研发需求修复,叠加行业订单价格企稳CRO企业底部向上趋势明确国内研发需求端边际改善,创新药出海BD带动研发积极性回升,国内研发订单需求增长,行业价格自2023年降价后已见底企稳,部分领域略有回升。目前原料药企业估值处于底部区间,重点关注新业务布局变化带来的个股机会。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1371515.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","02359","LU0320764599.SGD","LU1979443071.USD","LU2242644610.SGD","LU1934453819.USD","LU2488822045.USD","BK0028","01776","LU0052750758.USD","02315","LU0708995583.HKD","LU2125910500.SGD","BK1161","SG9999001093.SGD","BK0276","BK1564","BK1576","000776","SG9999014674.SGD","02268","BK1574","BK1141","BK1147","LU2045819591.USD","LU1046422090.SGD","01477","03347","BK1583","BK0183","BK0012","BK1191"],"gpt_icon":0},{"id":"2584900375","title":"港股异动 | 百奥赛图-B(02315)盘中涨近7% 科创板IPO下周初步询价 前三季度实现扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2584900375","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584900375?lang=zh_cn&edition=full","pubTime":"2025-11-20 14:17","pubTimestamp":1763619464,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,百奥赛图-B盘中涨近7%,截至发稿,涨4.03%,报31.52港元,成交额2122万港元。消息面上,百奥赛图发布首次公开发行股票并在科创板上市招股意向书,此次首次公开发行股票4750万股,公开发行股票的比例占本次发行后公司总股本的10.63%。值得注意的是,A股招股意向书中包含截至2025年9月30日止9个月的综合财务资料。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1371478.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688796","02315","BK1161","159982"],"gpt_icon":0},{"id":"2584971417","title":"百奥赛图-B(02315):A股发行将于11月25日进行初步询价","url":"https://stock-news.laohu8.com/highlight/detail?id=2584971417","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584971417?lang=zh_cn&edition=full","pubTime":"2025-11-20 06:47","pubTimestamp":1763592477,"startTime":"0","endTime":"0","summary":"智通财经APP讯,百奥赛图-B(02315)发布公告,诚如本公司日期为2025年10月16日的公告所披露,中国证监会已于2025年10月15日批准本公司的A股发行注册的申请。根据中国适用法律及法规的规定,本公司及主包销商将于初步询价日(即2025年11月25日(九时三十分至十五时正))在中国向符合中国法律及法规规定的询价对象进行初步询价,以厘定发行价格。建议A股发行的最终规模及发行价格一经厘定,本公司将另行刊发公告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1371302.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02315","159982","399300","688796"],"gpt_icon":0},{"id":"2584920325","title":"百奥赛图:首次公开发行股票并在科创板上市发行安排及询价公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2584920325","media":"公司公告","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584920325?lang=zh_cn&edition=full","pubTime":"2025-11-19 20:20","pubTimestamp":1763554805,"startTime":"0","endTime":"0","summary":"百奥赛图(北京)医药科技股份有限公司公告,公司拟在科创板首次公开发行4750万股股票,发行后总股本为44689.842万股。本次发行采用战略配售、网下发行与网上发行相结合的方式,初步询价时间为2025年11月25日,申购时间为2025年11月28日。网下投资者需满足市值要求并提交相关核查材料,定价将 综合 考虑公司投资价值、市场估值等因素。此外,部分网下发行股份设置6个月限售期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119203054a704607b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119203054a704607b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2584320920","title":"临床前CRO以及生物技术企业百奥赛图(688796.SH)拟于科创板IPO上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2584320920","media":"智通财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584320920?lang=zh_cn&edition=full","pubTime":"2025-11-19 19:30","pubTimestamp":1763551827,"startTime":"0","endTime":"0","summary":"智通财经APP讯,百奥赛图 发布首次公开发行股票并在科创板上市招股意向书,此次首次公开发行股票4750万股,公开发行股票的比例占本次发行后公司总股本的10.63%。发行人成立于2009年,是一家临床前CRO以及生物技术企业。本次发行上市的募集资金扣除发行费用后,将按轻重缓急顺序投资以下项目:药物早期研发服务平台建设项目、抗体药物研发及评价项目、临床前研发项目以及补充流动资金,募集资金投资额合计11.85亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119193604a704453d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119193604a704453d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":1},{"id":"2584692037","title":"百奥赛图-B11月19日遭主力抛售108.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584692037","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584692037?lang=zh_cn&edition=full","pubTime":"2025-11-19 16:15","pubTimestamp":1763540140,"startTime":"0","endTime":"0","summary":"11月19日, 百奥赛图-B股价跌8.84%,报收30.30元,成交金额3435.0万元,换手率1.00%,振幅10.71%,量比1.42。百奥赛图-B今日主力资金净流出108.7万元,连续3日净流出,上一交易日主力净流出7.1万元。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为57.14%,平均跌幅为3.67%。该股近5个交易日上涨0.53%,主力资金累计净流入95.6万元;近20日主力资金累计净流入198.4万元,其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119161853a4ac4655&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119161853a4ac4655&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2584959829","title":"百奥赛图-B11月18日遭主力抛售7.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584959829","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584959829?lang=zh_cn&edition=full","pubTime":"2025-11-18 16:15","pubTimestamp":1763453738,"startTime":"0","endTime":"0","summary":"11月18日, 百奥赛图-B股价跌1.01%,报收33.24元,成交金额1804.6万元,换手率0.50%,振幅5.48%,量比0.73。百奥赛图-B今日主力资金净流出7.1万元,上一交易日主力净流出105.2万元。该股近5个交易日上涨16.32%,主力资金累计净流入356.0万元;近20日主力资金累计净流入255.2万元,其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118161849a70155c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118161849a70155c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"1139577547","title":"港股生物医药股逆势走高!百济神州涨超7%,百奥赛图-B涨超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1139577547","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139577547?lang=zh_cn&edition=full","pubTime":"2025-11-13 09:42","pubTimestamp":1762998120,"startTime":"0","endTime":"0","summary":"11月13日,港股生物医药股逆势走高,$百济神州(06160)$涨超7%,$百奥赛图-B(02315)$涨超6%,$映恩生物-B(09606)$涨超5%,$三生制药(01530)$、$信达生物(01801)$、$来凯医药-B(02105)$涨超3%。","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","ONC","02315","LU2097828805.USD","LU0588546209.SGD","LU0455707207.USD","LU0502904849.HKD","LU2097828631.EUR","LU0307460666.USD","BK1593","LU1969619763.USD","01801","BK4139","LU2097828714.EUR","06160","09939","HK0000252160.HKD","BK4526","BK1588","BK1500","HK0000252152.HKD","LU2097828474.EUR","BK1589","LU2242644610.SGD","BK1161","02105","LU1251922891.USD","LU1303224171.USD","BK1583","LU1770034418.SGD","LU2328871848.SGD","HK0000500386.USD","09606","LU2543165471.USD","LU2097828557.USD","01530","HK0000165453.HKD","BK4585","LU1719994722.HKD"],"gpt_icon":0},{"id":"2582807674","title":"百奥赛图-B11月10日主力净流出63.4万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2582807674","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582807674?lang=zh_cn&edition=full","pubTime":"2025-11-10 16:15","pubTimestamp":1762762536,"startTime":"0","endTime":"0","summary":"11月10日,百奥赛图-B股价收平报28.00元,成交金额1151.1万元,换手率0.37%,振幅5.50%,量比1.05。百奥赛图-B今日主力资金净流出63.4万元,上一交易日主力净流出0万元。该股近5个交易日下跌4.17%,主力资金累计净流入67.1万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出294.8万元,其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110161840a6eef53c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110161840a6eef53c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bbctg.com.cn","stockEarnings":[{"period":"1week","weight":0.0126},{"period":"1month","weight":0.1314},{"period":"3month","weight":0.287},{"period":"6month","weight":0.84},{"period":"1year","weight":4.2787},{"period":"ytd","weight":2.7882}],"compareEarnings":[{"period":"1week","weight":0.0087},{"period":"1month","weight":0.0058},{"period":"3month","weight":0.0262},{"period":"6month","weight":0.0964},{"period":"1year","weight":0.3336},{"period":"ytd","weight":0.3004}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"百奥赛图(北京)医药科技股份有限公司是一家主要提供抗体药物研发和临床前研究服务的中国公司。该公司运营五个分部。基因编辑服务分部提供基于动物和细胞的定制化基因编辑服务。临床前药理药效评估分部提供用于药物疗效和毒性评估的临床前药理学服务。模式动物销售分部培育和销售外用和内用模式动物,亦向客户授出若干模式动物的许可。抗体开发分部识别有潜力成为候选药物的抗体,并就潜在治疗性抗体分子对外授权或与合作伙伴合作。创新药开发分部研发创新药,专注肿瘤学和自身免疫性疾病治疗。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.105956},{"month":2,"riseRate":0.666667,"avgChangeRate":0.052338},{"month":3,"riseRate":0.333333,"avgChangeRate":0.185414},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.066586},{"month":5,"riseRate":0.666667,"avgChangeRate":0.14952},{"month":6,"riseRate":0.333333,"avgChangeRate":0.011218},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.033427},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.055975},{"month":9,"riseRate":0.666667,"avgChangeRate":0.092895},{"month":10,"riseRate":0.25,"avgChangeRate":-0.096483},{"month":11,"riseRate":0.5,"avgChangeRate":0.009059},{"month":12,"riseRate":0.5,"avgChangeRate":0.113292}],"exchange":"SEHK","name":"百奥赛图-B","nameEN":"BIOCYTOGEN-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百奥赛图-B(02315)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百奥赛图-B(02315)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百奥赛图-B,02315,百奥赛图-B股票,百奥赛图-B股票老虎,百奥赛图-B股票老虎国际,百奥赛图-B行情,百奥赛图-B股票行情,百奥赛图-B股价,百奥赛图-B股市,百奥赛图-B股票价格,百奥赛图-B股票交易,百奥赛图-B股票购买,百奥赛图-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百奥赛图-B(02315)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百奥赛图-B(02315)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}